These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 25456084

  • 1. 4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII.
    SitaRam, Ceruso M, Khloya P, Supuran CT, Sharma PK.
    Bioorg Med Chem; 2014 Dec 15; 22(24):6945-52. PubMed ID: 25456084
    [Abstract] [Full Text] [Related]

  • 2. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P, Ceruso M, Ram S, Supuran CT, Sharma PK.
    Bioorg Med Chem Lett; 2015 Aug 15; 25(16):3208-12. PubMed ID: 26105196
    [Abstract] [Full Text] [Related]

  • 3. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII.
    Khloya P, Celik G, SitaRam, Vullo D, Supuran CT, Sharma PK.
    Eur J Med Chem; 2014 Apr 09; 76():284-90. PubMed ID: 24589484
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 09; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R, Vats L, Bua S, Supuran CT, Sharma PK.
    Eur J Med Chem; 2018 Jul 15; 155():545-551. PubMed ID: 29909339
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B, Ceruso M, Carta F, Supuran CT.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5883-90. PubMed ID: 25267005
    [Abstract] [Full Text] [Related]

  • 7. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Grandane A, Tanc M, Zalubovskis R, Supuran CT.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1256-60. PubMed ID: 24518190
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
    Winum JY, Innocenti A, Scozzafava A, Montero JL, Supuran CT.
    Bioorg Med Chem; 2009 May 15; 17(10):3649-52. PubMed ID: 19375921
    [Abstract] [Full Text] [Related]

  • 9. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J, Sprudza A, Tanc M, Vozny I, Zalubovskis R, Tars K, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5130-8. PubMed ID: 23859774
    [Abstract] [Full Text] [Related]

  • 10. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
    Rodríguez OM, Maresca A, Témpera CA, Bravo RD, Colinas PA, Supuran CT.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4447-50. PubMed ID: 21723123
    [Abstract] [Full Text] [Related]

  • 11. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam, Celik G, Khloya P, Vullo D, Supuran CT, Sharma PK.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1873-82. PubMed ID: 24560737
    [Abstract] [Full Text] [Related]

  • 12. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
    Angapelly S, Sri Ramya PV, Angeli A, Supuran CT, Arifuddin M.
    ChemMedChem; 2017 Oct 09; 12(19):1578-1584. PubMed ID: 28940980
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, Abou El Ella DA.
    Bioorg Med Chem; 2015 Aug 01; 23(15):4989-4999. PubMed ID: 26048024
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ, Ulus R, Aday B, Tanç M, Supuran CT, Kaya M.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6573-80. PubMed ID: 26422787
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z, Sławiński J, Saczewski F, Innocenti A, Supuran CT.
    Eur J Med Chem; 2010 Jun 15; 45(6):2396-404. PubMed ID: 20202722
    [Abstract] [Full Text] [Related]

  • 16. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS, Angapelly S, Angeli A, Digwal CS, Arifuddin M, Babu BN, Supuran CT, Kamal A.
    J Enzyme Inhib Med Chem; 2017 Dec 15; 32(1):1274-1281. PubMed ID: 28965419
    [Abstract] [Full Text] [Related]

  • 17. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
    Biswas S, McKenna R, Supuran CT.
    Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5646-9. PubMed ID: 23993330
    [Abstract] [Full Text] [Related]

  • 18. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5892-6. PubMed ID: 21852133
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Grandane A, Tanc M, Zalubovskis R, Supuran CT.
    Bioorg Med Chem; 2014 Mar 01; 22(5):1522-8. PubMed ID: 24513186
    [Abstract] [Full Text] [Related]

  • 20. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S.
    Eur J Med Chem; 2018 Jan 01; 143():1931-1941. PubMed ID: 29146134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.